Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Efficacy of Bismuth in Helicobacter pylori Eradication
IRCT20250529065965N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bismuth subsalicylate in Helicobacter pylori infection, sponsored by Kashan University of Medical Sciences. Started Apr 2024; status: completed.
02
Drugs
bismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20250529065965N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250529065965N1.